$4.20
0[0.00%]
At close: Apr 19
$4.20
0[0.00%]
After Hours: 7:58PM EDT
Bio-Path Hldgs
(NASDAQ:BPTH)Latest News for Bio-Path Hldgs Stock (NASDAQ:BPTH)
Bio-Path Hldgs Stock (NASDAQ: BPTH)
Categories: All
Friday, April 19, 2024
Thursday, April 18, 2024
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - 1 day ago
- Bio-Path Shares Resume Trade Following Circuit Breaker HaltBenzinga Newsdesk - 1 day ago
- Bio-Path Holdings Announces $1.2M Registered Direct Offering With Some Institutional Investors For Sale Of 375,000 Shares Of Its Common Stock At Price Of $3.225/ShareBenzinga Newsdesk - 1 day ago
- Roth MKM Reiterates Buy on Bio-Path Hldgs, Maintains $40 Price TargetBenzinga Newsdesk - 1 day ago
- Why Bio-Path Stock Is SoaringErica Kollmann - 1 day ago
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - 1 day ago
- Crude Oil Edges Lower; Bio-Path Holdings Shares Spike HigherAvi Kapoor - 1 day ago
- Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - 1 day ago
- Dow Surges Over 100 Points; D.R. Horton Posts Upbeat EarningsAvi Kapoor - 1 day ago
- Bio-Path Holdings Shares Resume TradeBenzinga Newsdesk - 1 day ago
- Market-Moving News for April 18thBenzinga Newsdesk - 1 day ago
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - 1 day ago
- Bio-Path Holdings shares are trading higher after the company announced the completion of its second dose cohort in Phase 1/1b clinical trial of BP1002 evaluating the ability of BP1002 to treat refractory/relapsed acute myeloid leukemia patientsBenzinga Newsdesk - 1 day ago
- Bio-Path Holdings Announces Completion Of Higher Dose Second Cohort In Phase 1/1b Clinical Trial Of BP1002 In Refractory/Relapsed Acute Myeloid Leukemia PatientsBenzinga Newsdesk - 1 day ago
Monday, April 15, 2024
Friday, March 08, 2024
- Why Bio-Path Holdings Shares Are Falling TodayNabaparna Bhattacharya - Mar 8, 2024, 12:17PM
- Bio-Path Reports Net Loss Of $33.63 Per Share For FY Ended December 31, 2023, Compared to Net Loss Of $38.12 Per Share YoY; As Of December-end Company Had Cash And Equivalents Of $1.1MBenzinga Newsdesk - Mar 8, 2024, 7:09AM
- Earnings Scheduled For March 8, 2024Benzinga Insights - Mar 8, 2024, 5:54AM
Thursday, March 07, 2024
Friday, February 23, 2024
Wednesday, February 21, 2024
Wednesday, January 10, 2024
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Jan 10, 2024, 8:05AM
- Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia PatientsBenzinga Newsdesk - Jan 10, 2024, 7:02AM
Thursday, December 14, 2023
Monday, November 27, 2023
Friday, November 24, 2023
Wednesday, November 15, 2023
Tuesday, November 14, 2023
Wednesday, November 08, 2023
Thursday, October 19, 2023
Wednesday, October 18, 2023
Tuesday, October 17, 2023
Monday, October 16, 2023
- Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - Oct 16, 2023, 1:09PM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Oct 16, 2023, 9:05AM
- Why ContraFect Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving PremarketLisa Levin - Oct 16, 2023, 8:47AM
Friday, October 13, 2023
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Oct 13, 2023, 1:31PM
- Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Oct 13, 2023, 1:14PM
- What's Going On With Bio-Path Holdings Stock?Erica Kollmann - Oct 13, 2023, 10:32AM
- Dow Jumps Over 200 Points; JPMorgan Earnings Top EstimatesLisa Levin - Oct 13, 2023, 9:48AM
- Bio-Path Shares Resume TradeBenzinga Newsdesk - Oct 13, 2023, 9:44AM
- Bio-Path Shares Halted On Circuit Breaker To The Downside, Stock Now Up 110.6%Benzinga Newsdesk - Oct 13, 2023, 9:40AM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Oct 13, 2023, 9:06AM
- Why Comtech Telecommunications Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving PremarketLisa Levin - Oct 13, 2023, 7:35AM